Hospital Santa Izabel, Salvador, BA, Brazil.
J Cardiopulm Rehabil Prev. 2012 May-Jun;32(3):141-6. doi: 10.1097/HCR.0b013e31824f9ddf.
While patients with heart failure who achieve a peak oxygen uptake (peak VO2) of 10 mL·kg(-1)·min(-1) or less are often considered for intensive surveillance or intervention, those achieving 14 mL·kg(-1)·min(-1) or more are generally considered to be at lower risk. Among patients in the "intermediate" range of 10.1 to 13.9 mL·kg(-1)·min(-1), optimally stratifying risk remains a challenge.
Patients with heart failure (N = 1167) referred for cardiopulmonary exercise testing were observed for 21 ± 13 months. Patients were classified into 3 groups of peak VO2 (≤10, 10.1-13.9, and ≥14 mL·kg(-1)·min(-1)). The ability of heart rate recovery at 1 minute (HRR1) and the minute ventilation/carbon dioxide output (VE/VCO2) slope to complement peak VO2 in predicting cardiovascular mortality were determined.
Peak VO2, HRR1 (<16 beats per minute), and the VE/VCO2 slope (>34) were independent predictors of mortality (hazard ratio 1.6, 95% CI: 1.2-2.29, P = .006; hazard ratio 1.7, 95% CI: 1.1-2.5, P = .008; and hazard ratio 2.4, 95% CI: 1.6-3.4, P < .001, respectively). Compared with those achieving a peak VO2 ≥ 14 mL·kg(-1)·min(-1), patients within the intermediate range with either an abnormal VE/VCO2 slope or HRR1 had a nearly 2-fold higher risk of cardiac mortality. Those with both an abnormal HRR1 and VE/VCO2 slope had a higher mortality risk than those with a peak VO2 ≤ 10 mL·kg(-1)·min(-1). Survival was not different between those with a peak VO2 ≤ 10 mL·kg(-1)·min(-1) and those in the intermediate range with either an abnormal HRR1 or VE/VCO2 slope.
HRR1 and the VE/VCO2 slope effectively stratify patients with peak VO2 within the intermediate range into distinct groups at high and low risk.
虽然达到峰值摄氧量(peak VO2)10 毫升/公斤/分钟或以下的心力衰竭患者通常被认为需要进行强化监测或干预,但达到 14 毫升/公斤/分钟或更高的患者通常被认为风险较低。在 10.1 至 13.9 毫升/公斤/分钟的“中间”范围内的患者中,最佳风险分层仍然是一个挑战。
对接受心肺运动测试的心力衰竭患者(N=1167)进行了 21±13 个月的观察。患者被分为 3 组峰值 VO2(≤10、10.1-13.9 和≥14 毫升/公斤/分钟)。确定心率恢复 1 分钟(HRR1)和分钟通气/二氧化碳输出(VE/VCO2)斜率在预测心血管死亡率方面对峰值 VO2的补充作用。
峰值 VO2、HRR1(<16 次/分钟)和 VE/VCO2 斜率(>34)是死亡率的独立预测因素(危险比 1.6,95%可信区间:1.2-2.29,P=0.006;危险比 1.7,95%可信区间:1.1-2.5,P=0.008;和危险比 2.4,95%可信区间:1.6-3.4,P<.001)。与达到峰值 VO2≥14 毫升/公斤/分钟的患者相比,中间范围内的患者,无论 VE/VCO2 斜率或 HRR1 是否异常,其心脏死亡率的风险几乎增加了两倍。同时存在异常 HRR1 和 VE/VCO2 斜率的患者的死亡率风险高于峰值 VO2≤10 毫升/公斤/分钟的患者。峰值 VO2≤10 毫升/公斤/分钟的患者和中间范围内的 HRR1 或 VE/VCO2 斜率异常的患者之间的生存没有差异。
HRR1 和 VE/VCO2 斜率有效地将峰值 VO2 处于中间范围内的患者分为高风险和低风险的不同组。